Physician

Robert C Brown, M.D.

According to 2025 Medicare claims, Robert Brown, M.D. (NPI: 1932223526) practices obstetrics/gynecology in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is UROLOGY ASSOCIATES OF MOBILE, P.A. (NPI: 1194828368; TIN: 63-0576885) and primary practice location at 36532-3160.

Brown's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 333 traditional Medicare patients, billed 3,502 HCPCS/CPT codes, and received $218,800 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 861 prescription claims across 352 beneficiaries totaling $212,376 in drug costs, led by Gemtesa (Vibegron). 2022 DME data shows 18 claims. Open Payments data shows 43 records totaling $76,031. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $61,492 to $218,800. Similarly, Part D prescription costs have moved sharply higher in recent years, from $108,827 to $212,376. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	328	1,262	$61,492
2016	296	1,110	$48,894
2017	203	893	$49,224
2018	203	823	$46,676
2019	220	1,062	$49,145
2020	178	811	$67,267
2021	261	3,149	$218,821
2022	329	4,515	$265,921
2023	360	2,814	$209,557
2024	333	3,502	$218,800

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	213	1,021	$108,827
2016	192	861	$108,965
2017	193	816	$97,997
2018	208	989	$127,603
2019	223	895	$118,433
2020	226	910	$105,505
2021	301	1,075	$166,294
2022	360	998	$175,265
2023	432	1,104	$242,956
2024	352	861	$212,376

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	18	$3,917
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	85	85	$143
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	176	317	$124
99442	Telephone medical discussion with physician, 11-20 minutes	108	151	$61
99459	Pelvic exam	158	240	$15
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	190	277	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	115	6,022	$93,483
Myrbetriq	Mirabegron	91	5,015	$72,785
Premarin	Estrogens, Conjugated	45	4,291	$18,722
Estradiol	Estradiol	99	7,748	$4,513
Estradiol (Twice Weekly)	Estradiol	16	896	$2,082

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	40	$1,017	Axonics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$75,014	Axonics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert C. Brown, M.D.?

Tedicare shows public-source Medicare data for Robert C. Brown, M.D. (NPI 1932223526), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert C. Brown, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert C. Brown, M.D.?

Robert C. Brown, M.D. is linked to UROLOGY ASSOCIATES OF MOBILE, P.A. (billing NPI 1194828368) in the available physician profile data.

Does Robert C. Brown, M.D. have Open Payments data?

Robert C. Brown, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.